Traws Historical Balance Sheet
| TRAW Stock | 5.02 0.31 5.82% |
Trend analysis of Traws Pharma balance sheet accounts such as Property Plant And Equipment Net of 29.8 K, Current Deferred Revenue of 180.8 K, Accounts Payable of 4.7 M or Cash of 34.4 M provides information on Traws Pharma's total assets, liabilities, and equity, which is the actual value of Traws Pharma to its prevalent stockholders. By breaking down trends over time using Traws Pharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Traws Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Traws Pharma is a good buy for the upcoming year.
Traws Pharma Inventory |
|
Traws |
About Traws Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Traws Pharma at a specified time, usually calculated after every quarter, six months, or one year. Traws Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Traws Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Traws currently owns. An asset can also be divided into two categories, current and non-current.
Traws Pharma Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Traws Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Traws Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Traws Pharma balance sheet. This account contains Traws Pharma investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Traws Pharma fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Most accounts from Traws Pharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Traws Pharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Traws Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.At this time, Traws Pharma's Common Stock is fairly stable compared to the past year. Net Invested Capital is likely to climb to about 18.3 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 6.7 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 3.1M | 4.0M | 3.4M | 3.1M | Total Assets | 55.5M | 39.4M | 22.7M | 35.5M |
Traws Pharma balance sheet Correlations
Click cells to compare fundamentals
Traws Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.